Amicus Therapeutics Inc’s filing revealed that its Chief People Officer Clark David Michael unloaded Company’s shares for reported $0.36 million on Dec 19 ’25. In the deal valued at $14.17 per share,25,642 shares were sold. As a result of this transaction, Clark David Michael now holds 245,690 shares worth roughly $3.49 million.
Then, DAVID CLARK bought 25,642 shares, generating $279,241 in total proceeds.
Before that, Campbell Bradley L sold 77,926 shares. Amicus Therapeutics Inc shares valued at $846,011 were divested by the President and CEO at a price of $10.86 per share. As a result of the transaction, Campbell Bradley L now holds 1,129,782 shares, worth roughly $16.05 million.
TD Cowen downgraded its Amicus Therapeutics Inc [FOLD] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Needham also remained covering FOLD and has increased its forecast on September 18, 2025 with a “Buy” recommendation from previously “Hold” rating. Morgan Stanley revised its rating on July 17, 2025. It rated FOLD as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of FOLD
On Tuesday, Amicus Therapeutics Inc [NASDAQ:FOLD] saw its stock unchanged to $14.21. Over the last five days, the stock has gained 30.49%. Amicus Therapeutics Inc shares have risen nearly 46.04% since the year began. Nevertheless, the stocks have risen 50.85% over the past one year. While a 52-week high of $14.36 was reached on 12/19/25, a 52-week low of $5.51 was recorded on 06/25/25.
Levels Of Support And Resistance For FOLD Stock
The 24-hour chart illustrates a support level at 14.19, which if violated will result in even more drops to 14.16. On the upside, there is a resistance level at 14.23. A further resistance level may holdings at 14.24.
How much short interest is there in Amicus Therapeutics Inc?
A steep rise in short interest was recorded in Amicus Therapeutics Inc stocks on 2025-11-28, growing by 2.26 million shares to a total of 19.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 17.05 million shares. There was a rise of 11.69%, which implies that there is a positive sentiment for the stock.
